Life science companies face unique cybersecurity risks. See how your security posture measures up.
The potential impact of a cyberattack to a life sciences company is complex. On the line is highly critical intellectual property and patient information, production delays or lost batches of high-cost product, and even brand identity. No one wants to be the drug maker that can’t provide critical medication to patients in need.
While the ROI of security is found in risk avoidance, we’ve seen time and time again how this risk translates into direct material impact on company valuation and the bottom line. Remember the $310 million lost by one pharmaceutical company due to NotPetya? No organization is immune.
The good news is, pharma and biotech companies have been dealing with security-related regulations, data integrity and compliance requirements for some time. But as technology evolves, so do vulnerabilities, meaning vigilance is a must.
Take a minute and ask yourself the following questions about your current cyber hygiene practices and how you measure up.